ALBENDAMAX- 11.36% albendazole oral suspension 
Vetr, LLC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

Albendamax (albendazole oral suspension)

Important
Accurate estimates of the weight of the cattle, sheep, and goats to be treated are essential for effective results. Animals consistently exposed to internal parasites should be retreated as necessary.

Residue Warnings
Cattle must not be slaughtered within 27 days following last treatment. Sheep and Goats must not be slaughtered within 7 days following last treatment. A withdrawal time in milk has not been established; Do not use in female breeding dairy cattle. Do not use in lactating female sheep or goats.

Other Warnings
Parasite resistance may develop to any dewormer, and has been reported for most classes of dewormers. Treatment with a dewormers AND parasite management practices appropriate to the region and the animal(s) treated may slow the development of parasite resistance. Fecal examinations or other diagnostic tests should be used to determine if this product is appropriate, prior to the use of any dewormer. Following the use of any dewormer, effectiveness of treatment should be monitored, e.g., fecal egg count reduction test. A decrease in a drug’s effectiveness over time as calculated by fecal egg count reduction tests may indicate the development of resistance to the dewormer administered. Your parasite management plan should be adjusted accordingly.

Precaution
Do not administer to female cattle during first 45 days of pregnancy or for 45 days after removal of bulls. Do not administer to ewes or does during the first 30 days of pregnancy or for 30 days after removal of rams or bucks. Consult your veterinarian for assistance in the diagnosis, treatment, and control of parasitism.

Albendamax Suspension should be administered to cattle and goats at the recommended rate of 4 mL/100 lb of body weight (equivalent to 4.54 mg of albendazole/lb, 10 mg/kg) and to sheep at the recommended rate of 0.75 mL/25 lb of body weight (equivalent to 3.4 mg of albendazole/lb, 7.5 mg/kg). Do not underdose. Ensure each animal receives a complete dose based on a current body weight. Underdosing may result in ineffective treatment, and encourage the development of parasite resistance.

NOT FOR HUMAN USE. KEEP AWAY FROM CHILDREN. Use only as directed.

Store at Controlled Room Temperature 20° – 25°C (68° – 77°F)

Protect From Freezing

Albendazole 11.36% oral suspension (113.6 mg/mL)

Albendamax 240 mL

Albendamax 500 mL

Albendamax 960 mL

Albendamax 1893 mL

Albendamax 3785 mL

ALBENDAMAX 
11.36% albendazole oral suspension
Product Information
Product TypeOTC ANIMAL DRUGItem Code (Source)NDC:86213-442
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ALBENDAZOLE (UNII: F4216019LN) (ALBENDAZOLE - UNII:F4216019LN) ALBENDAZOLE113.6 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
CARBOXYMETHYLCELLULOSE SODIUM (UNII: K679OBS311) 6 mg  in 1 mL
GLYCERIN (UNII: PDC6A3C0OX)  
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)  
POLYSORBATE 80 (UNII: 6OZP39ZG8H)  
BENZOIC ACID (UNII: 8SKN0B0MIM)  
Product Characteristics
ColorwhiteScore    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:86213-442-01240 mL in 1 BOTTLE, PLASTIC
2NDC:86213-442-02500 mL in 1 BOTTLE, PLASTIC
3NDC:86213-442-03960 mL in 1 BOTTLE, PLASTIC
4NDC:86213-442-041893 mL in 1 BOTTLE, PLASTIC
5NDC:86213-442-053785 mL in 1 BOTTLE, PLASTIC
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other03/27/2026
Labeler - Vetr, LLC (132219984)
Establishment
NameAddressID/FEIBusiness Operations
Vetr, LLC132219984manufacture, label
Establishment
NameAddressID/FEIBusiness Operations
Alivira Animal Health650916617api manufacture

Revised: 3/2026
 
Vetr, LLC